ROS-mediated DNA methylation pattern alterations in carcinogenesis

Current Drug Targets

Volumn 16, Issue 1, 2015, Pages 13-19

  Wu, Qihan ^a,b   Ni, Xiaohua ^a  

^a SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

5 hydroxymethylcytosine (5hmC); 8 hydroxy 2' deoxyguanosine (8 OHdG); Carcinogenesis; DNA methylation; DNA methyltransferases (DNMTs); Reactive oxygen species (ROS); Tumor suppressor gene (TSG)

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 8 HYDROXYDEOXYGUANOSINE; ATM PROTEIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; ENDONUCLEASE; ENDONUCLEASE APEX1; HISTONE DEACETYLASE 1; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYCOMB GROUP PROTEIN; POLYCOMB GROUP PROTEIN 4; PROTEIN P53; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SUPEROXIDE; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR RUNX1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DNA METHYLTRANSFERASE; TUMOR MARKER;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; CPG ISLAND; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA METHYLATION; DNA REPLICATION; EPIGENETICS; GENE SILENCING; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; INFLAMMATION; MACROPHAGE ACTIVATION; METASTASIS; MUTATION; NEOPLASM; OXIDATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM;

ANIMALS; CARCINOGENESIS; DNA METHYLATION; DNA MODIFICATION METHYLASES; EPIGENESIS, GENETIC; HUMANS; REACTIVE OXYGEN SPECIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84922272549     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450116666150113121054     Document Type: Article

References (81)

1. Novak K. Epigenetics changes in cancer cells. MedGenMed 2004; 6(4): 17.
2. Esteller M. Cancer epigenomics: DNA methylomes and histonemodification maps. Nat Rev Genet 2007; 8(4): 286-98.
3. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4(2): 143-53.
4. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3(6): 415-28.
5. Campos AC, Molognoni F, Melo FH, et al. Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. Neoplasia 2007; 9(12): 1111-21.
6. Lee KW, Lee HJ. Biphasic effects of dietary antioxidants on oxidative stress-mediated carcinogenesis. Mech Ageing Dev 2006; 127(5): 424-31.
7. Herath NI, Leggett BA, MacDonald GA. Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol 2006; 21(1 Pt 1): 15-21.
8. Ziech D, Franco R, Pappa A, et al. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 2011; 711(1-2): 167-73.
9. Devasagayam TP, Tilak JC, Boloor KK, et al. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 2004; 52: 794-804.
10. Tudek B, Winczura A, Janik J, et al. Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am J Transl Res 2010; 2(3): 254-84.
11. Panayiotidis M. Reactive oxygen species (ROS) in multistage carcinogenesis. Cancer Lett 2008; 266(1): 3-5.
12. Franco R, Panayiotidis MI. Environmental toxicity, oxidative stress, human disease and the "black box" of their synergism: how much have we revealed? Mutat Res 2009; 674(1-2): 1-2.
13. Lister R, Pelizzola M, Dowen RH, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462(7271): 315-22.
14. Ehrlich M, Gama-Sosa MA, Huang LH, et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res 1982; 10(8): 2709-21.
15. Dodge JE, Ramsahoye BH, Wo ZG, et al. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene 2002; 289(1-2): 41-8.
16. Haines TR, Rodenhiser DI, Ainsworth PJ. Allele-specific non-CpG methylation of the Nf1 gene during early mouse development. Dev Biol 2001; 240(2): 585-98.
17. Lister R, Mukamel EA, Nery JR, et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013, 341(6146): 1237905.
18. Bird A, Taggart M, Frommer M, et al. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 1985; 40(1): 91-9.
19. Bestor T, Laudano A, Mattaliano R, et al. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 1988; 203(4): 971-83.
20. Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998; 19(3): 219-20.
21. Bestor TH. Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J 1992, 11(7): 2611-7.
22. Leonhardt H, Page AW, Weier HU, et al. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 1992; 71(5): 865-73.
23. Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99(3): 247-57.
24. Chen T, Ueda Y, Dodge JE, et al. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol Cell Biol 2003; 23(16): 5594-605.
25. Gowher H, Liebert K, Hermann A, et al. Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)-methyltransferases by Dnmt3L. J Biol Chem 2005; 280(14): 13341-8.
26. Goll MG, Kirpekar F, Maggert KA, et al. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 2006; 311(5759): 395-8.
27. Takusagawa F, Kamitori S, Markham GD. Structure and function of S-adenosylmethionine synthetase: crystal structures of Sadenosylmethionine synthetase with ADP, BrADP, and PPi at 28 angstroms resolution. Biochemistry 1996; 35(8): 2586-96.
28. Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 2013; 502(7472): 472-9.
29. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349(21): 2042-54.
30. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol 2005; 45: 629-56.
31. Rideout WM, 3rd, Coetzee GA, Olumi AF, et al. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990; 249(4974): 1288-90.
32. Pfeifer GP, Tang M, Denissenko MF. Mutation hotspots and DNA methylation. Curr Top Microbiol Immunol 2000; 249: 1-19.
33. el-Deiry WS, Nelkin BD, Celano P, et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 1991; 88(8): 3470-4.
34. Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res 2010; 44(5): 479-96.
35. Jha P, Pia Patric IR, Shukla S, et al. Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation. Neuro Oncol 2014; 16(12): 1607-17.
36. Nohl H, Kozlov AV, Gille L, et al. Cell respiration and formation of reactive oxygen species: facts and artefacts. Biochem Soc Trans 2003; 31(Pt 6): 1308-11.
37. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005; 10: 1881-96.
38. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51(3): 794-8.
39. Babior BM. NADPH oxidase: an update. Blood 1999; 93(5): 1464-76.
40. Babior BM. The respiratory burst oxidase. Curr Opin Hematol 1995, 2(1): 55-60.
41. Segal AW, Shatwell KP. The NADPH oxidase of phagocytic leukocytes. Ann N Y Acad Sci 1997; 832: 215-22.
42. Bensaad K, Vousden KH. Savior and slayer: the two faces of p53. Nat Med 2005; 11(12): 1278-9.
43. Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 2006, 12(4): 446-51.
44. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radical Biology and Medicine 2000; 29(3-4): 323-33.
45. Vaquero EC, Edderkaoui M, Pandol SJ, et al. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. Journal of Biological Chemistry 2004; 279(33): 34643-54.
46. Urbano A, Lakshmanan U, Choo PH, et al. AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells. Embo Journal 2005; 24(15): 2815-26.
47. Karin M. Nuclear factor-kappa B in cancer development and progression. Nature 2006; 441(7092): 431-36.
48. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005; 10: 1881-96.
49. Mori K, Shibanuma M, Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 2004; 64(20): 7464-72.
50. Okada F, Kobayashi M, Tanaka H, et al. The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. Am J Pathol 2006; 169(1): 294-302.
51. Nishikawa M, Hyoudou K, Kobayashi Y, et al. Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes. J Control Release 2005; 109(1-3): 101-07.
52. Heirman I, Ginneberge D, Brigelius-Flohe B, et al. Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy. Free Radic Biol Med 2006; 40(2): 285-94.
53. Okada F, Shionoya H, Kobayashi M, et al. Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase. Br J Cancer 2006; 94(6): 854-62.
54. Lim SO, Gu JM, Kim MS, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008; 135(6): 2128-40, 40 e1-8.
55. Quan X, Lim SO, Jung G. Reactive oxygen species downregulate catalase expression via methylation of a CpG island in the Oct-1 promoter. FEBS Lett 2011; 585(21): 3436-41.
56. Valko M, Rhodes CJ, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160(1): 1-40.
57. Weitzman SA, Turk PW, Milkowski DH, et al. Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci USA 1994; 91(4): 1261-4.
58. Turk PW, Laayoun A, Smith SS, et al. DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 1995; 16(5): 1253-5.
59. Grollman AP, Moriya M: Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 1993; 9(7): 246-9.
60. Comparative analysis of baseline 8-oxo-7, 8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 2002; 23(12): 2129-33.
61. Pfeifer GP. Mutagenesis at methylated CpG sequences. DNA Methylation: Basic Mechanisms 2006; 301: 259-81.
62. Kasymov RD, Grin IR, Endutkin AV, et al. Excision of 8-oxoguanine from methylated CpG dinucleotides by human 8-oxoguanine DNA glycosylase. FEBS Lett 2013; 587(18): 3129-34.
63. Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 2007; 67(3): 946-50.
64. Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell 2011; 146(6): 866-72.
65. Jin SG, Kadam S, Pfeifer GP. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 2010; 38(11): e125.
66. Valinluck V, Tsai HH, Rogstad DK, et al. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 2004; 32(14): 4100-8.
67. Fouse SD, Nagarajan RO, Costello JF. Genome-scale DNA methylation analysis. Epigenomics 2010; 2(1): 105-17.
68. Afanas'ev I. New nucleophilic mechanisms of ros-dependent epigenetic modifications: comparison of aging and cancer. Aging Dis 2014; 5(1): 52-62.
69. Vilkaitis G, Merkiene E, Serva S, et al. The mechanism of DNA cytosine-5 methylation. Kinetic and mutational dissection of Hhai methyltransferase. J Biol Chem 2001; 276(24): 20924-34.
70. Gerasimaite R, Merkiene E, Klimasauskas S. Direct observation of cytosine flipping and covalent catalysis in a DNA methyltransferase. Nucleic Acids Res 2011; 39(9): 3771-80.
71. Fan W, Luo J. SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Mol Cell 2010; 39(2): 247-58.
72. Espada J, Ballestar E, Santoro R, et al. Epigenetic disruption of ribosomal RNA genes and nucleolar architecture in DNA methyltransferase 1 (Dnmt1) deficient cells. Nucleic Acids Res 2007; 35(7): 2191-8.
73. Vire E, Brenner C, Deplus R, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439(7078): 871-4.
74. Mortusewicz O, Schermelleh L, Walter J, et al. Recruitment of DNA methyltransferase I to DNA repair sites. Proc Natl Acad Sci USA 2005; 102(25): 8905-9.
75. O'Hagan HM, Mohammad HP, Baylin SB. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet 2008; 4(8): e1000155.
76. MacLeod AR, Rouleau J, Szyf M. Regulation of DNA methylation by the Ras signaling pathway. J Biol Chem 1995; 270(19): 11327-37.
77. Kang KA, Zhang R, Kim GY, et al. Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumour Biol 2012; 33(2): 403-12.
78. Fuks F, Burgers WA, Brehm A, et al. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet 2000; 24(1): 88-91.
79. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005; 15(5): 490-5.
80. Shao D, Fry JL, Han J, et al. A redox-resistant sirtuin-1 mutant protects against hepatic metabolic and oxidant stress. J Biol Chem 2014; 289(11): 7293-306.
81. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10(5): 295-304.